Hepatology

Hepatology is the flagship monthly peer-reviewed journal of the American Association for the Study of Liver Diseases and is published by Lippincott Williams & Wilkins, founded in 1981, covering all aspects of liver structure, function and disease, with a 2025 Journal Impact Factor of 18.0《肝病学》是美国肝病研究学会（AASLD）的旗舰月刊同行评审期刊，由（Lippincott Williams & Wilkins）出版，1981 年创办，涵盖肝脏结构、功能与疾病的各个方面，2025 年影响因子为 18.0。

Scope

• It publishes original peer-reviewed research on all aspects of liver structure, function and disease该刊刊载有关肝脏结构、功能与疾病各方面的原创同行评审研究。^[1]
• Its coverage includes immunology and chronic and viral hepatitis其覆盖范围包括免疫学以及慢性肝炎与病毒性肝炎。
• Its topics include cirrhosis and genetic and metabolic liver diseases其主题包括肝硬化以及遗传性与代谢性肝病。^[2]
• It also covers liver cancer and alcohol-associated liver disease该刊还涵盖肝癌与酒精相关肝病。
• Drug metabolism and drug-induced liver injury fall within its scope药物代谢与药物性肝损伤也属于其范围。
• Its editorial board selects the most impactful advances in basic, translational and clinical science each month其编委会每月遴选基础、转化与临床科学中最具影响力的进展。

History

• It was established in 1981 by the American Association for the Study of Liver Diseases该刊由美国肝病研究学会于 1981 年创办。
• Its first issue debuted in January and February 1981, with Irwin M. Arias as the inaugural Editor-in-Chief其创刊号于 1981 年 1 至 2 月面世，首任主编为 Irwin M. Arias。
• It is published by Lippincott Williams & Wilkins on behalf of the association该刊由（Lippincott Williams & Wilkins）代表该学会出版。
• It appears monthly with twelve issues a year该刊按月出版，每年十二期。
• Its volume numbering reached Volume 84 in 2026至 2026 年其卷号已达第 84 卷。
• Its Journal Impact Factor rose from 17.425 in 2021 to 18.0 in 2025其影响因子由 2021 年的 17.425 升至 2025 年的 18.0。

Editors

• Its Editor-in-Chief is Gregory J. Gores其现任主编为 Gregory J. Gores。
• In December 2025 the association named Naga Chalasani and Laura E. Nagy as incoming Co-Editors-in-Chief2025 年 12 月，该学会任命 Naga Chalasani 与 Laura E. Nagy 为候任联席主编。
• They will begin reviewing submissions in July 2026 ahead of a five-year term starting in January 2027二人将于 2026 年 7 月开始审阅投稿，其五年任期自 2027 年 1 月起。
• Naga Chalasani is a professor of medicine at Indiana University School of MedicineNaga Chalasani 是（Indiana University School of Medicine）的医学教授。
• Laura E. Nagy is professor of molecular medicine at Cleveland ClinicLaura E. Nagy 是（Cleveland Clinic）的分子医学教授。
• The journal is peer reviewed and its editors draw on leaders in hepatology worldwide该刊实行同行评审，其编辑汇集了全球肝病学领域的领军者。